Ameera Shah-led Metropolis Healthcare Limited, India’s second-largest and most respected pathology laboratory chain, today announced its collaboration with Roche Diagnostics India and Neighbouring ...

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

Labcorp forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on ...

Guillain-Barré Syndrome (GBS) poses a diagnostic challenge due to its misleading symptoms, the lack of a definitive test, and ...

The issue of whether [Williams] has the capacity to assess what is in her own best interests deserves renewed careful consideration by qualified experts,” a court filing read.

When given the opportunity, individuals will cheat to feel smarter or healthier, engaging in diagnostic self-deception to convince themselves that their performance is due to their ability and not the ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...

It’s tough for a man to know what to do following a diagnosis of prostate cancer. The treatment is often worse than the risk ...

A new study suggests that a simple blood test could help doctors quickly determine whether a stroke is caused by bleeding or ...